Innovate Biopharmaceuticals Competitors and Similar CompaniesClear all
Innovate Biopharmaceuticals's competitors and similar companies include CSL Behring, Cipla, Ipsen and Chiesi Group.
 Innovate Biopharmaceuticals Innovate Biopharmaceuticals is a biotechnology company developing medicines for autoimmune and inflammatory diseases. |  Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products. |  Chiesi Group Chiesi Group (Gruppo Chiesi, also known as CHIESI Farmaceutici) is a company that researches, develops, produces, and commercializes therapeutic solutions. | |||
Founding Date | Founding Date 2012 | Founding Date 1904 | Founding Date 1935 | Founding Date 1929 | Founding Date 1935 |
Type | Type Private | Type Subsidiary | Type Public | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Raleigh, US HQ | Locations King of Prussia, US HQ Broadmeadows, AU Parkville, AU Parkville, AU Wien, AT Mechelen, BE see more | Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more | Locations Boulogne-Billancourt, FR HQ Algiers, DZ South Yarra, AU Wien, AT Merelbeke, BE São Paulo, BR Mississauga, CA see more | Locations Parma, IT HQ Melbourne, AU Wien, AT Machelen, BE Santana De Parnaíba, BR São Paulo, BR Sofia, BG see more |
Employees | Employees 8 | Employees 7,5692% decrease | Employees 27,764 | Employees 5,358 | Employees 5,8541% increase |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $7.9b (FY, 2020) | Revenue (est.) ₹277.1b (FY, 2026) | Revenue (est.) €3.7b (FY, 2025) | Revenue (est.) €2.4b (Y, 2021) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods ₹95.5b (FY, 2026) | Cost of goods €659.1m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $4.5b (FY, 2020) | Gross profit ₹195b (FY, 2026) | Gross profit €3.3b (FY, 2025) | Gross profit N/A |
Net income | Net income ($43.8m) (FY, 2022) | Net income N/A | Net income ₹38.7b (FY, 2026) | Net income €445.1m (FY, 2025) | Net income N/A |
Operating ⚠ | |||||
Manufacturing Sites | Manufacturing Sites N/A | Manufacturing Sites N/A | Manufacturing Sites 46 (FY, 2024) | Manufacturing Sites N/A | Manufacturing Sites 3 (Y, 2021) |
For sources of this data, please see the company profile
View Company Profiles
Cipla
HQ
Mumbai, IN
Employees
27,764
Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.
View companyChiesi Group
HQ
Parma, IT
Chiesi Group (Gruppo Chiesi, also known as CHIESI Farmaceutici) is a company that researches, develops, produces, and commercializes therapeutic solutions.
View company